296 related articles for article (PubMed ID: 14682374)
1. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
Vecil GG; Lang FF
J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
Shah AC; Benos D; Gillespie GY; Markert JM
J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
Jiang H; Gomez-Manzano C; Lang FF; Alemany R; Fueyo J
Curr Gene Ther; 2009 Oct; 9(5):422-7. PubMed ID: 19860656
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene therapy in high-grade malignant glioma.
Pedersini R; Vattemi E; Claudio PP
Drug News Perspect; 2010; 23(6):368-79. PubMed ID: 20697604
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials with retrovirus mediated gene therapy--what have we learned?
Rainov NG; Ren H
J Neurooncol; 2003 Dec; 65(3):227-36. PubMed ID: 14682373
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral gene therapy in head and neck cancer.
Vattemi E; Claudio PP
Drug News Perspect; 2006; 19(6):329-37. PubMed ID: 16971969
[TBL] [Abstract][Full Text] [Related]
7. Conditionally replicative adenoviral vectors for malignant glioma.
Sonabend AM; Ulasov IV; Lesniak MS
Rev Med Virol; 2006; 16(2):99-115. PubMed ID: 16416455
[TBL] [Abstract][Full Text] [Related]
8. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
Nettelbeck DM
Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
[TBL] [Abstract][Full Text] [Related]
9. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
[TBL] [Abstract][Full Text] [Related]
10. Engineering regulatory elements for conditionally-replicative adeno-viruses.
Haviv YS; Curiel DT
Curr Gene Ther; 2003 Aug; 3(4):357-85. PubMed ID: 12871022
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic adenoviral therapy for glioblastoma multiforme.
Sonabend AM; Ulasov IV; Han Y; Lesniak MS
Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
[TBL] [Abstract][Full Text] [Related]
12. Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond.
Warren RS; Kirn DH
Surg Oncol Clin N Am; 2002 Jul; 11(3):571-88, vi. PubMed ID: 12487057
[TBL] [Abstract][Full Text] [Related]
13. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
14. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.
Lang FF; Bruner JM; Fuller GN; Aldape K; Prados MD; Chang S; Berger MS; McDermott MW; Kunwar SM; Junck LR; Chandler W; Zwiebel JA; Kaplan RS; Yung WK
J Clin Oncol; 2003 Jul; 21(13):2508-18. PubMed ID: 12839017
[TBL] [Abstract][Full Text] [Related]
16. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
[TBL] [Abstract][Full Text] [Related]
18. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
[TBL] [Abstract][Full Text] [Related]
19. An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma.
Arafat WO; Buchsbaum DJ; Gómez-Navarro J; Tawil SA; Olsen C; Xiang J; El-Akad H; Salama AM; Badib AO; Stackhouse MA; Curiel DT
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1037-50. PubMed ID: 12605984
[TBL] [Abstract][Full Text] [Related]
20. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
